INOVIO PHARMACEUTICALS, INC. Accounts Payable and Accrued Liabilities, Current
INOVIO PHARMACEUTICALS, INC. (INO) had Accounts Payable and Accrued Liabilities, Current of $24.75 million as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2023-05-10
- 2023-03-31: Accounts Payable and Accrued Liabilities, Current $24.75M.
- 2022-12-31: Accounts Payable and Accrued Liabilities, Current $79.69M.
- 2022-09-30: Accounts Payable and Accrued Liabilities, Current $74.15M.
- 2022-06-30: Accounts Payable and Accrued Liabilities, Current $105.02M.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2023-03-31 | $24.75M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $79.69M 10-Q · filed 2023-05-10 |
| 2022-09-30 | $74.15M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $105.02M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $38.12M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $47.64M 10-K · filed 2023-03-01 |
| 2021-09-30 | $28.65M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $30.10M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $25.97M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $21.20M 10-K · filed 2022-03-01 |
| 2020-09-30 | $23.53M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $17.22M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $11.02M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $18.24M 10-K · filed 2021-03-01 |
| 2019-09-30 | $9.78M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $13.39M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $15.64M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $23.13M 10-K · filed 2020-03-12 |
| 2018-09-30 | $17.32M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $12.61M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $15.83M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $23.28M 10-K · filed 2019-03-12 |
| 2017-09-30 | $22.53M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $16.48M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $14.47M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $19.60M 10-K · filed 2018-03-14 |
| 2016-09-30 | $16.18M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $12.71M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $12.10M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $13.06M 10-K · filed 2017-03-15 |
| 2015-09-30 | $10.52M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $6.07M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $4.45M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $6.38M 10-K · filed 2016-03-14 |
| 2014-09-30 | $4.70M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $5.29M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $5.25M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $5.44M 10-K · filed 2015-03-16 |
| 2013-09-30 | $4.02M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $3.34M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $2.57M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $3.18M 10-K · filed 2014-03-17 |
| 2012-09-30 | $3.13M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $3.52M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $3.32M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $4.32M 10-K · filed 2013-03-18 |
| 2011-09-30 | $3.29M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $3.24M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $3.41M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |